Should I buy or sell Yatharth Hospital Tra Ca Ser?

The average broker rating on Yatharth Hospital Tra Ca Ser is Sell. The breakup of analyst rating is given below - 0.00 analysts have given a strong sell rating 1 analysts have given a sell rating 0.00 analysts have given a hold rating 0.00 analysts have given a buy rating 0.00 analysts have given a strong buy rating

Is Yatharth Hospital Tra Ca Ser a good stock to invest in?

Yatharth Hospital Tra Ca Ser can be analyzed on the following key metrics - TTM P/E: 37.33 Sector P/E: 23.06 Dividend Yield: 0% D/E ratio: -

Yatharth Hospital Tra Ca Ser Share Price

Sector:

Powered by

499.60 +12.05 (2.47%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 479.15

Today’s High 508.30

52 Week Low 345.35

52 Week High 692.85

Key Metrics

Market Cap (In Cr) 4793.71
Beta -
Div. Yield (%) 0
P/B 4.78
TTM P/E 37.33
Peg Ratio 0.36
Sector P/E 23.06
Open Price 479.15
Prev Close 487.55

View All Metrics

Yatharth Hospital Tra Ca Ser Analysis

Price Analysis

1 Week

-4.12%
3 Months

9.98%
6 Month

-25.02%
YTD

-14.04%
1 Year

8.86%

Risk Meter

42% Low risk
42% Moderate risk
42% Balanced Risk
42% High risk
42% Extreme risk

Recos

Strong Sell
Sell
Hold
Buy
Strong Buy

Analysts' Views

Ratings
Current
1 W Ago
1 M Ago
3 M Ago

Strong Buy
0.00
0.00
0.00
0.00

Buy
0.00
0.00
0.00
1

Hold
0.00
0.00
0.00
0.00

Sell
1
1
1
0.00

Strong Sell
0.00
0.00
0.00
0.00

Total
1
1
1
1

Yatharth Hospital Tra Ca Ser News

Smallcap hospital stock Yatharth Hospital stock soars 90% since IPO; Phillip Capital sees another 44% upside (REUTERS)

Premium

THIS smallcap hospital stock up 90% since IPO; another 44% upside seen

3 min read . 30 Sep 2024

SMIFS maintains a ‘buy’ call on Yatharth Hospital with a target price of ₹650, citing growth potential. (REUTERS)

Premium

Up 36% from IPO price, SMIFS sees another 60% upside in this hospital stock

3 min read . 28 May 2024

Yatharth Hospitals: The brokerage initiated coverage with a ‘buy’ call on the stock with a target price of ₹658. (Photo Courtesy: Yatharth Hospitals website)

Premium

Yatharth Hospitals: 6 key reasons why SMIFS sees 36% upside in the stock

5 min read . 28 Feb 2024

On August 7, 2023, the company's shares debuted on the Indian stock exchanges with a listing gain of 11% at ₹333 apiece, as compared to the issue price of ₹300. (Photo: Courtesy Yatharth Hospital website)

Premium

Yatharth Hospital shares surge over 10% on stellar Q2 performance

2 min read . 08 Nov 2023

View More News

Yatharth Hospital Tra Ca Ser Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2024

Total Revenue
670.55

Selling/ General/ Admin Expenses Total
278.47

Depreciation/ Amortization
29.3

Other Operating Expenses Total
43.39

Total Operating Expense
499.11

Operating Income
171.44

Net Income Before Taxes
156.83

Net Income
114.48

Diluted Normalized EPS
14.44

Period
2023

Total Revenue
520.29

Selling/ General/ Admin Expenses Total
219.52

Depreciation/ Amortization
27.51

Other Operating Expenses Total
47.44

Total Operating Expense
401.11

Operating Income
119.18

Net Income Before Taxes
87.68

Net Income
65.77

Diluted Normalized EPS
7.66

Period
2022

Total Revenue
400.94

Selling/ General/ Admin Expenses Total
155.74

Depreciation/ Amortization
27.87

Other Operating Expenses Total
29.7

Total Operating Expense
306.82

Operating Income
94.11

Net Income Before Taxes
63.11

Net Income
44.16

Diluted Normalized EPS
5.14

Period
2021

Total Revenue
228.67

Selling/ General/ Admin Expenses Total
84.82

Depreciation/ Amortization
20.56

Other Operating Expenses Total
16.97

Total Operating Expense
178

Operating Income
50.68

Net Income Before Taxes
28.12

Net Income
18.16

Diluted Normalized EPS
2.12

Period
2020

Total Revenue
146.04

Selling/ General/ Admin Expenses Total
59.39

Depreciation/ Amortization
21.29

Other Operating Expenses Total
12.06

Total Operating Expense
126.44

Operating Income
19.6

Net Income Before Taxes
-2.49

Net Income
-1.3

Diluted Normalized EPS
-0.15

Period
2019

Total Revenue
101.83

Selling/ General/ Admin Expenses Total
44.09

Depreciation/ Amortization
8.38

Other Operating Expenses Total
11.11

Total Operating Expense
87.72

Operating Income
14.11

Net Income Before Taxes
5.02

Net Income
3.98

Diluted Normalized EPS
0.46

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Yatharth Hospital Tra Ca Ser Technical

Moving Average SMA

5 Day505.04
10 Day492
20 Day463.34

50 Day419.78
100 Day478.56
300 Day510.08

Yatharth Hospital Tra Ca Ser Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Indus Infra Trust Unt
108.1
-1.27
-1.16
118.51
95.21
4788.17

Unimech Aerospace Manufacturing
891.85
-30.1
-3.26
1523.6
851.2
4521.2

Yatharth Hospital Tra Ca Ser
499.6
12.05
2.47
692.85
345.35
4793.71

Awfis Space Solutions
645
-14.25
-2.16
945.7
371.75
4589.99

Sundaram-clayton
2071.95
-14.6
-0.7
2933
1395
4599.93

Yatharth Hospital Tra Ca Ser Shareholding

Shareholding Pattern

*Promoter pledging: 8.51%

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

27-Jan-25
Quarterly Results

07-Nov-24
Quarterly Results

13-Aug-24
Quarterly Results

23-May-24
Audited Results

10-Feb-24
Quarterly Results

07-Nov-23
Quarterly Results

17-Aug-23
Quarterly Results

Meeting Date
Announced on
Purpose

06-Dec-24
14-Nov-24
EGM

28-Sept-24
05-Sept-24
AGM

28-Sept-23
07-Sept-23
AGM

View All

Company Profile

ABOUT Yatharth Hospital Tra Ca Ser

ISIN INE0JO301016
BSE Code 543950
NSE Code YATHARTH

Yatharth Hospital & Trauma Care Services Limited is engaged in providing healthcare services, operating hospitals and other allied services. Its facilities include amenities, guidelines for admission, visitor policy, helpdesk, empanelment’s, and preventive health checkup. It provides a spectrum of specialty services in the fields of Cardiology, Neurosciences, Pediatrics, Gastroenterology, Pulmonology, Robotic Surgery, Dermatology, Endocrinology, Dentistry, Radiology, Ophthalmology, Cancer & Bone Marrow Transplant, Nephrology & Urology, General Surgery, Psychology & Psychiatry, Plastic & Cosmetic Surgery, Vitro Fertilization (IVF) & Fertility, and Interventional Spine & Pain Medicine. It also provides Nuclear Medicine, Pathology & Laboratory Medicine, Nutrition & Health, Physiotherapy & Rehab, Emergency Medicine, and more. It has hospitals in Greater Noida, Noida, Noida Extension, Jhansi Orchha, and Faridabad. It also has a super-specialty hospital located in Model Town, New Delhi.

MANAGEMENT

Ajay Tyagi Executive Chairman of the Board, Whole Time Director
Amit Singh Group Chief Executive Officer
Pankaj Prabhakar Group Chief Financial Officer
Nitin Gupta Group Chief Operating Officer, President - Finance
Ritesh Mishra Compliance Officer, Company Secretary
Kapil Kumar Managing Director
Sonu Goyal Group Chief Financial Controller
Yatharth Tyagi Whole Time Director

YATHARTH HOSPITAL TRA CA SER SUMMARY

Yatharth Hospital Tra Ca Ser is trading 2.47% upper at Rs 499.60 as compared to its last closing price. Yatharth Hospital Tra Ca Ser has been trading in the price range of 508.30 & 479.15. Yatharth Hospital Tra Ca Ser has given -14.04% in this year & -4.12% in the last 5 days.

Yatharth Hospital Tra Ca Ser has TTM P/E ratio 37.33 as compared to the sector P/E of 23.06. There are 1 analysts who have initiated coverage on Yatharth Hospital Tra Ca Ser. There are 0.00 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.

The company posted a net profit of 30.49 Crores in its last quarter.

Listed peers of Yatharth Hospital Tra Ca Ser include Indus Infra Trust Unt (-1.16%), Unimech Aerospace Manufacturing (-3.26%), Yatharth Hospital Tra Ca Ser (2.47%) etc.

Yatharth Hospital Tra Ca Ser has a 61.64% promoter holding & 38.36% public holding.

FAQs about Yatharth Hospital Tra Ca Ser

Yatharth Hospital Tra Ca Ser is trading at 499.60 as on 28 Apr, 2025 3:29:18 PM. This is 2.47% upper as compared to its previous closing price of 487.55

The market capitalization of Yatharth Hospital Tra Ca Ser is 4793.71 Cr as on 28 Apr, 2025 3:29:18 PM.

The average broker rating on Yatharth Hospital Tra Ca Ser is Sell. The breakup of analyst rating is given below -

0.00 analysts have given a strong sell rating
1 analysts have given a sell rating
0.00 analysts have given a hold rating
0.00 analysts have given a buy rating
0.00 analysts have given a strong buy rating

The 52 wk high for Yatharth Hospital Tra Ca Ser is 692.85 whereas the 52 wk low is 345.35

Yatharth Hospital Tra Ca Ser can be analyzed on the following key metrics -

TTM P/E: 37.33
Sector P/E: 23.06
Dividend Yield: 0%
D/E ratio: -

Yatharth Hospital Tra Ca Ser reported a net profit of 114.48 Cr in 2024.

Yatharth Hospital Tra Ca Ser Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Yatharth Hospital Tra Ca Ser Share Price

Price Range

Price Range

Key Metrics

Yatharth Hospital Tra Ca Ser Analysis

Yatharth Hospital Tra Ca Ser News

THIS smallcap hospital stock up 90% since IPO; another 44% upside seen

Up 36% from IPO price, SMIFS sees another 60% upside in this hospital stock

Yatharth Hospitals: 6 key reasons why SMIFS sees 36% upside in the stock

Yatharth Hospital shares surge over 10% on stellar Q2 performance

Yatharth Hospital Tra Ca Ser Financials

Forecast

Forecast

Forecast

Yatharth Hospital Tra Ca Ser Technical

Yatharth Hospital Tra Ca Ser Peers

Yatharth Hospital Tra Ca Ser Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Yatharth Hospital Tra Ca Ser

MANAGEMENT

YATHARTH HOSPITAL TRA CA SER SUMMARY

FAQs about Yatharth Hospital Tra Ca Ser

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue